Moderna's (MRNA) BA.4/BA.5 Targeting Bivalent Booster, mRNA-1273.222, Meets Primary Endpoint of Superiority Against Omicron Variants
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/25/2026
Go back to Moderna's (MRNA) BA.4/BA.5 Targeting Bivalent Booster, mRNA-1273.222, Meets Primary Endpoint of Superiority Against Omicron Variants
November 14, 2022 12:06 PM EST
Moderna (NASDAQ: MRNA) Extends Gain, Up 6.5%
...
More